Given the low MC we don't get much analyst coverage so I found this a little encouraging (small steps). I remember that Morgans ditched talking to and about PYC last year after becoming frustrated like all of us...
"I caught up with Richard Hopkins yesterday - Richard has recently taken over as CEO of Phylogica was formerly the COO. The message was fairly simple - focus on an area/s where can add real value to pharma - that value add seems to be getting drugs into cells - or as they have termed it (functional penetrating peptides). Sounds like pharma have a genuine interest working with PYC. Following a recent capital raising PYC has a two year run way with A$6m in bank. Share price looks much healthier and looks like heading higher."
Given the low MC we don't get much analyst coverage so I found...
Add to My Watchlist
What is My Watchlist?
 (20min delay)
|
|||||
|
Last
$1.25 |
Change
-0.025(1.96%) |
Mkt cap ! $729.0M | |||
| Open | High | Low | Value | Volume |
| $1.28 | $1.29 | $1.24 | $366.8K | 291.5K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 3 | 18585 | $1.24 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $1.28 | 1377 | 1 |
View Market Depth
| Last trade - 16.10pm 09/05/2025 (20 minute delay) ? |
| PYC (ASX) Chart |